UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 192

Sortiert nach

Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer

Oncogene, 2016-03, Vol.35 (13), p.1619-1631

2016

Link zum Volltext

Verfügbarkeit prüfen

PG 5.03 Molecular mechanisms in gastric cancer: Basis for therapy?

European journal of cancer (1990), 2012-03, Vol.48, p.S5-S5

Seruca, R

2012

Link zum Volltext

Verfügbarkeit prüfen

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program

Virchows Archiv : an international journal of pathology, 2008-11, Vol.453 (5), p.417-431

2008

Link zum Volltext

Verfügbarkeit prüfen

Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer

Journal of clinical pathology, 2008-01, Vol.61 (1), p.25-30

2008

Link zum Volltext

Verfügbarkeit prüfen

KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression

Oncogene, 2007-01, Vol.26 (1), p.158-163

2007

Link zum Volltext

Verfügbarkeit prüfen

The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin

Human molecular genetics, 2009-07, Vol.18 (14), p.2599-2608

2009

Link zum Volltext

Verfügbarkeit prüfen

The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers

Oncogene, 2008-07, Vol.27 (30), p.4255-4260

2008

Link zum Volltext

Verfügbarkeit prüfen

Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells

Oncogene, 2010-01, Vol.29 (3), p.392-402

2010

Link zum Volltext

Verfügbarkeit prüfen

Atomic force microscopy and graph analysis to study the P-cadherin/SFK mechanotransduction signalling in breast cancer cells

Nanoscale, 2016-11, Vol.8 (46), p.19390-19401

2016

Link zum Volltext

Verfügbarkeit prüfen

E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma

Oncogene, 2001-03, Vol.20 (12), p.1525-1528

2001

Link zum Volltext

Verfügbarkeit prüfen

BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing

Journal of medical genetics, 2004-09, Vol.41 (9), p.664-668

2004

Link zum Volltext

Verfügbarkeit prüfen

Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria

Journal of medical genetics, 2004-07, Vol.41 (7), p.508-517

2004

Link zum Volltext

Verfügbarkeit prüfen

552: CDH3/P-cadherin is negatively regulated by TAp63 in a p53-dependent manner in breast cancer cells: Effects on P-cadherin-mediated invasion and self-renewal

European journal of cancer (1990), 2014-07, Vol.50, p.S133-S133

2014

Link zum Volltext

Verfügbarkeit prüfen

Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer

Journal of medical genetics, 2006-02, Vol.43 (2), p.138-142

2006

Link zum Volltext

Verfügbarkeit prüfen

BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations

The Journal of pathology, 2008-02, Vol.214 (3), p.320-327

2008

Link zum Volltext

Verfügbarkeit prüfen

930: Effect of radiotherapy on macrophages

European journal of cancer (1990), 2014-07, Vol.50, p.S228-S228

2014

Link zum Volltext

Verfügbarkeit prüfen

The interferon gamma receptor 1 (IFNGR1) −56C/T gene polymorphism is associated with increased risk of early gastric carcinoma

Gut, 2008-11, Vol.57 (11), p.1504-1508

2008

Link zum Volltext

Verfügbarkeit prüfen

Identification of seven novel germline mutations in the human E-cadherin (CDH1) Gene

Human mutation, 2007-02, Vol.28 (2), p.203-203

2007

Link zum Volltext

Verfügbarkeit prüfen

OC-0501: The role of radiotherapy on macrophages and on macrophage-cancer cell communication

Radiotherapy and oncology, 2015-04, Vol.115, p.S246-S246

2015

Link zum Volltext

Verfügbarkeit prüfen

452 P-cadherin Activates Src-kinase – a New Signaling Pathway With Implications in Breast Cancer Progression

European journal of cancer (1990), 2012-07, Vol.48, p.S108-S108

2012

Link zum Volltext

Verfügbarkeit prüfen

319 DNAJB4 Differentially Regulates WT and Mutant E-cadherin in Cancer

European journal of cancer (1990), 2012-07, Vol.48, p.S78-S78

2012

Link zum Volltext

Verfügbarkeit prüfen

Identification of seven novel germline mutations in the human E‐cadherin (CDH1) Gene

Human mutation, 2007-02, Vol.28 (2), p.203-203

2007

Link zum Volltext

Verfügbarkeit prüfen

Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients

Journal of medical genetics, 2004-06, Vol.41 (6), p.e89-e89

2004

Link zum Volltext

Verfügbarkeit prüfen

Microsatellite instability at multiple loci in gastric carcinoma: Clinicopathologic implications and prognosis

Gastroenterology (New York, N.Y. 1943), 1996-01, Vol.110 (1), p.38-44

1996

Link zum Volltext

Verfügbarkeit prüfen

1055 Bacterial Protein Azurin as a New Candidate Drug to Treat P-cadherin Overexpressing Breast Cancer

European journal of cancer (1990), 2012-07, Vol.48, p.S255-S255

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 192

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(166)
Mit Volltextzugriff
(188)

Publikationsform

Artikel
(191)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(133)
Science & Technology
(127)
Life Sciences & Biomedicine
(124)
Biological And Medical Sciences
(80)
Stomach Neoplasms - Genetics
(79)
Medical Sciences
(69)
Oncology
(66)
Tumors
(65)
Female
(58)
Male
(58)
Genetics & Heredity
(54)
Adult
(51)
Mutation
(47)
Gastroenterology. Liver. Pancreas. Abdomen
(43)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(43)
Middle Aged
(41)
Cadherins - Genetics
(36)
Stomach Neoplasms - Pathology
(36)
Aged
(30)
Biochemistry & Molecular Biology
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer

PG 5.03 Molecular mechanisms in gastric cancer: Basis for therapy?

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program

Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer

KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression

The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin

The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers

Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells

Atomic force microscopy and graph analysis to study the P-cadherin/SFK mechanotransduction signalling in breast cancer cells

E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma

BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing

Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria

552: CDH3/P-cadherin is negatively regulated by TAp63 in a p53-dependent manner in breast cancer cells: Effects on P-cadherin-mediated invasion and self-renewal

Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer

BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations

930: Effect of radiotherapy on macrophages

The interferon gamma receptor 1 (IFNGR1) −56C/T gene polymorphism is associated with increased risk of early gastric carcinoma

Identification of seven novel germline mutations in the human E-cadherin (CDH1) Gene

OC-0501: The role of radiotherapy on macrophages and on macrophage-cancer cell communication

452 P-cadherin Activates Src-kinase – a New Signaling Pathway With Implications in Breast Cancer Progression

319 DNAJB4 Differentially Regulates WT and Mutant E-cadherin in Cancer

Identification of seven novel germline mutations in the human E‐cadherin (CDH1) Gene

Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients

Microsatellite instability at multiple loci in gastric carcinoma: Clinicopathologic implications and prognosis

1055 Bacterial Protein Azurin as a New Candidate Drug to Treat P-cadherin Overexpressing Breast Cancer

Suchergebnisse filtern